SubHero Banner

lamivudine/nevirapine/zidovudine – New drug approval

August 13, 2018 - The FDA approved Micro Labs’ lamivudine/nevirapine/zidovudine, for use alone as a complete regimen or in combination with other antiretroviral drugs for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 35 kg.

Download PDF